{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:26:08Z","timestamp":1789943168227,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"vor","delay-in-days":2961,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1194\/jlr.p025437","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T02:38:42Z","timestamp":1341283122000},"page":"1968-1978","source":"Crossref","is-referenced-by-count":24,"title":["Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPAR\u03b3 deficiency"],"prefix":"10.1016","volume":"53","author":[{"given":"Philippe M.","family":"Campeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Astapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Leff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Gagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.P025437_bib1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1194\/jlr.R700004-JLR200","article-title":"Thematic review series: adipocyte biology. Lipodystrophies: windows on adipose biology and metabolism","volume":"48","author":"Hegele","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P025437_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.ejhg.5201430","article-title":"High-throughput pedigree drawing","volume":"13","author":"M\u00e4kinen","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1194\/jlr.P025437_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.clinbiochem.2004.03.008","article-title":"Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with [beta]-quantification in a large population","volume":"37","author":"Tremblay","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1194\/jlr.P025437_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1194\/jlr.P025437_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bbrc.2006.03.187","article-title":"Gene polymorphisms in the Quebec population: a risk to develop hypertriglyceridemia","volume":"344","author":"Garenc","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.P025437_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1194\/jlr.P025437_bib8","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes."},{"key":"10.1194\/jlr.P025437_bib9","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P025437_bib10","first-page":"59","article-title":"Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a\/c gene","volume":"86","author":"Garg","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.P025437_bib11","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.P025437_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/01.wnl.0000255939.73424.f8","article-title":"Muscle and nerve pathology in Dunnigan familial partial lipodystrophy","volume":"68","author":"Spuler","year":"2007","journal-title":"Neurology."},{"key":"10.1194\/jlr.P025437_bib13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.P025437_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00125-003-1037-4","article-title":"A dominant negative PPARgamma mutant shows altered cofactor recruitment and inhibits adipogenesis in 3T3\u2013L1 cells","volume":"46","author":"Park","year":"2003","journal-title":"Diabetologia."},{"key":"10.1194\/jlr.P025437_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0022-2836(03)00316-4","article-title":"Molecular dynamics studies of a molecular switch in the glucocorticoid receptor","volume":"328","author":"Stockner","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1194\/jlr.P025437_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/me.2006-0401","article-title":"Altered promoter recycling rates contribute to dominant-negative activity of human peroxisome proliferator-activated receptor-gamma mutations associated with diabetes","volume":"21","author":"Li","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1194\/jlr.P025437_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-7-3","article-title":"Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)","volume":"7","author":"Francis","year":"2006","journal-title":"BMC Med. Genet."},{"key":"10.1194\/jlr.P025437_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0090-6980(00)00075-7","article-title":"PPARgamma: observations in the hematopoietic system","volume":"62","author":"Greene","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1194\/jlr.P025437_bib19","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/MCB.01651-09","article-title":"Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages","volume":"30","author":"Lefterova","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1194\/jlr.P025437_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.clpt.6100146","article-title":"Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus","volume":"82","author":"Berria","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1194\/jlr.P025437_bib21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.exphem.2005.05.003","article-title":"Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation","volume":"33","author":"Nagasawa","year":"2005","journal-title":"Exp. Hematol."},{"key":"10.1194\/jlr.P025437_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-143-6-200509200-00016","article-title":"Leukopenia and thrombocytopenia caused by thiazolidinediones","volume":"143","author":"Digman","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1194\/jlr.P025437_bib25","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/diacare.28.6.1536","article-title":"Mild, reversible pancytopenia induced by rosiglitazone","volume":"28","author":"Maaravi","year":"2005","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.P025437_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature08099","article-title":"Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment","volume":"460","author":"Naveiras","year":"2009","journal-title":"Nature."},{"key":"10.1194\/jlr.P025437_bib27","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1182\/blood-2009-09-246173","article-title":"Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function","volume":"115","author":"Chitteti","year":"2010","journal-title":"Blood."},{"key":"10.1194\/jlr.P025437_bib28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbalip.2007.02.005","article-title":"PPARgamma in immunity and inflammation: cell types and diseases","volume":"1771","author":"Sz\u00e9les","year":"2007","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.P025437_bib31","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1100\/tsw.2010.213","article-title":"The nuclear hormone receptor PPARgamma as a therapeutic target in major diseases","volume":"10","author":"Schmidt","year":"2010","journal-title":"ScientificWorldJournal."},{"key":"10.1194\/jlr.P025437_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/31860","article-title":"Allosteric effects of DNA on transcriptional regulators","volume":"392","author":"Lefstin","year":"1998","journal-title":"Nature."},{"key":"10.1194\/jlr.P025437_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.gde.2006.02.009","article-title":"The proteasome: a utility tool for transcription?","volume":"16","author":"Collins","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1194\/jlr.P025437_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/oby.2008.616","article-title":"PPAR-gamma AF-2 domain functions as a component of a ubiquitin-dependent degradation signal","volume":"17","author":"Kilroy","year":"2009","journal-title":"Obesity (Silver Spring)."},{"key":"10.1194\/jlr.P025437_bib35","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1101\/gad.501108","article-title":"Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis","volume":"22","author":"Nielsen","year":"2008","journal-title":"Genes Dev."},{"key":"10.1194\/jlr.P025437_bib36","unstructured":"De Benoist, B., McLean, E., Egli, I., Cogswell, M., . 2008. Worldwide prevalence of anaemia 1993\u20132005, WHO Global Database on Anemia. In, . World Health Organization, Geneva. 41."},{"key":"10.1194\/jlr.P025437_bib4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1194\/jlr.P025437_bib23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2337\/diacare.27.6.1324","article-title":"Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm","volume":"27","author":"Saad","year":"2004","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.P025437_bib24","first-page":"462","article-title":"Marrow suppression with myelodysplastic features, hypoerythropoetinemia, and lipotrophic proptosis due to rosiglitazone","volume":"108","author":"Clevidence","year":"2009","journal-title":"WMJ."},{"key":"10.1194\/jlr.P025437_bib29","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1084\/jem.20082771","article-title":"The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity","volume":"206","author":"Klotz","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1194\/jlr.P025437_bib30","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1172\/JCI13202","article-title":"Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis","volume":"108","author":"Setoguchi","year":"2001","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520418395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520418395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.P025437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T22:48:43Z","timestamp":1637448523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520418395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0022227520418395"],"URL":"https:\/\/doi.org\/10.1194\/jlr.p025437","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}